| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $49K | — | +122.7% |
| SG&A Expense | $1.1M | — | +27.3% |
| Operating Income | -$1.3M | — | -46.9% |
| Net Income | $681K | — | +114.8% |
| EPS (Basic) | $0.05 | — | +66.7% |
| EPS (Diluted) | $0.05 | — | +66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.1M | -3.8% | -18.3% |
| Current Assets | $14.6M | -5.4% | -18.7% |
| Total Assets | $14.6M | -5.4% | -18.7% |
| Current Liabilities | $2.1M | -42.6% | -57.8% |
| Stockholders' Equity | $12.6M | +5.8% | -4.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$563K | — | +64.8% |
| Investing Cash Flow | $0 | — | -100.0% |